These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18490422)

  • 41. Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study.
    de Souza AW; Keusseyan SP; da Silva NP; Sato EI; Andrade LE
    Rev Bras Reumatol; 2012; 52(3):357-65. PubMed ID: 22641590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-(DNA-histone) antibodies in active lupus nephritis.
    Suenaga R; Abdou NI
    J Rheumatol; 1996 Feb; 23(2):279-84. PubMed ID: 8882032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
    Suzuki N; Harada T; Mizushima Y; Sakane T
    J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.
    Grootscholten C; van Bruggen MC; van der Pijl JW; de Jong EM; Ligtenberg G; Derksen RH; Berden JH;
    Arthritis Rheum; 2003 May; 48(5):1355-62. PubMed ID: 12746908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The binding of lupus-derived autoantibodies to the C-terminal peptide (83-119) of the major SmD1 autoantigen can be mediated by double-stranded DNA and nucleosomes.
    Dieker JW; Van Bavel CC; Riemekasten G; Berden JH; van der Vlag J
    Ann Rheum Dis; 2006 Nov; 65(11):1525-8. PubMed ID: 16540553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti-DNA and anti-heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice.
    Hylkema MN; van Bruggen MC; van de Lagemaat R; Kramers K; Berden JH; Smeenk RJ
    J Autoimmun; 1996 Feb; 9(1):41-50. PubMed ID: 8845053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of lupus nephritis: a review.
    McLigeyo SO
    East Afr Med J; 1998 Nov; 75(11):628-31. PubMed ID: 10065172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-DNA antibody subpopulations and lupus nephritis.
    Rekvig OP; Kalaaji M; Nossent H
    Autoimmun Rev; 2004 Feb; 3(2):1-6. PubMed ID: 15003181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.
    Lefkowith JB; Kiehl M; Rubenstein J; DiValerio R; Bernstein K; Kahl L; Rubin RL; Gourley M
    J Clin Invest; 1996 Sep; 98(6):1373-80. PubMed ID: 8823302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
    Mohan C; Adams S; Stanik V; Datta SK
    J Exp Med; 1993 May; 177(5):1367-81. PubMed ID: 8478612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
    Ng KP; Manson JJ; Rahman A; Isenberg DA
    Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic specificities and sensitivities of anti dsDNA, anti membrane DNA and anti nucleosomes autoantibodies.
    Servais G; Daens S; Guillaume MP; Cumps J; Duchateau J; Peretz A
    Scand J Clin Lab Invest Suppl; 2001; 235():61-7. PubMed ID: 11712694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two paradoxes and a surprise on the road to an understanding of systemic lupus erythematosus.
    Salaman MR
    Immunol Lett; 2012; 148(1):49-52. PubMed ID: 22841962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE.
    Marsman G; Stephan F; de Leeuw K; Bulder I; Ruinard JT; de Jong J; Westra J; Bultink IE; Voskuyl AE; Aarden LA; Luken BM; Kallenberg CG; Zeerleder S
    Eur J Immunol; 2016 Mar; 46(3):762-71. PubMed ID: 26626052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.
    Doria A; Gatto M
    Lupus; 2012 Dec; 21(14):1492-6. PubMed ID: 23042821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systemic lupus erythematosus and nucleosome].
    Mukai M
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):127-35. PubMed ID: 16819261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.